Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC. | Financial_Report.xls |
| 10-Q - 10-Q - ORAMED PHARMACEUTICALS INC. | zk1516032.htm |
| EX-31.2 - EXHIBIT 31.2 - ORAMED PHARMACEUTICALS INC. | exhibit_31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - ORAMED PHARMACEUTICALS INC. | exhibit_32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ORAMED PHARMACEUTICALS INC. | exhibit_31-1.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the quarterly report of Oramed Pharmaceuticals Inc., or the Company, on Form 10-Q for the period ended November 30, 2014 as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Nadav Kidron, President, Chief Executive Officer and a Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, that to my knowledge:
|
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
|
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Dated: January 7, 2015
|
/s/ Nadav Kidron
|
|
|
Nadav Kidron, President and Chief Executive Officer
|